ArticleOncotarget2016

T-cell epitope strength in WAP-T mouse mammary carcinomas is an important determinant in PD1/PD-L1 immune checkpoint blockade therapy.

Michael Bruns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.